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Purpose: To use the clinical and radiological data to differentiate non-cholesterol versus cholesterol gall bladder (GB) polyps, 
which can be useful in deciding the treatment of the patient. Methods: One hundred and eighty-seven patients underwent 
cholecystectomy for GB polyps of around 10 mm for 10 years, and were divided into two groups, cholesterol polyps (146 pa-
tients) and non-cholesterol polyps (41 patients) based on the postoperative pathological findings. Gender, age, body weight, 
height, body mass index (BMI), symptoms, laboratory findings, size, number of polyps, presence of GB stone and maximum 
diameter measured by preoperative ultrasonography (USG), computed tomography (CT), and pathological diameter were 
subjected to comparative analysis. Results: Patients diagnosed with cholesterol polyps were younger in age and had higher 
BMI, and the total cholesterol levels and white blood cell levels were higher, but were not statistically significant. It was nota-
ble to see that 28.6% of the cholesterol polyps were not found in the preoperative CT yet the percentage of the undetectable 
rate was significantly lower (8%) in the non-cholesterol polyp group. There was a discrepancy in maximum diameters be-
tween the two radiological methods in both groups but the discrepancy was significantly larger in the cholesterol polyp 
group. Conclusion: The clinical signs that can be helpful to diagnose whether it is a cholesterol polyp or not are younger pa-
tients who have high BMI, polyps which are detectable only on the USG and large maximum diameters between the USG 
and CT. And if the discrepancy of the maximum diameter is lesser than 1mm the polyp may be considered as a non-choles-
terol polyp.
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INTRODUCTION
Polypoid lesions of the gallbladder may be defined as 
elevations on the mucosa of the gall bladder (GB) which af-
fect 4 to 6% of the normal population [1-3]. As the radio-
logic tools such as ultrasonography (USG) and computed 
tomography (CT) develop, the frequency of detecting 
many diseases, such as GB polyps, has increased [1-4]. To 
distinguish between a benign polyp and a malignant pol-
yp is very important because untreated malignant GB pol-
yps have a poor prognosis. And because of the poor prog-
nosis, early diagnosis and early treatment are very im-Clinical and radiologic preoperative predicting factors for GB cholesterol polyp
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Table 1. Clinical data
Clinical data 
Non-cholesterol 
polyp
Cholesterol 
polyp
P-value
Sex
Female 17 (9.1)   62 (33.2)
Male  24 (12.8)   84 (44.9)
Total  41 (21.9) 146 (78.1)
Age (yr) 45 40  0.024
Height (cm) 163.54 ± 9.03 165.69 ± 8.89 0.19
Weight (kg)    61.88 ± 10.98     67.60 ± 12.30 0.08
Body mass index (kg/m
2) 22.51 24.36 0.01
Glutamic oxaloacetic 
  transaminase (IU/L)
24 23 0.89
Glutamic pyruvic 
  transaminase (IU/L) 
22 24 0.13
Total bilirubin (mg/dL)  0.81   0.82 0.53
Direct bilirubin (mg/dL)  0.19   0.24 0.11
White blood cell 
  (10
3/mm
3)
6.1 6.3 0.02
Cholesterol (mg/dL) 181.48 ± 38.45 185.02 ± 34.3   0.6
Symptoms (pain) (n) 5 7
Values are presented as number (%) or mean ± SD.
portant [5-8]. 
Currently, there are predicting factors that are useful to 
distinguish benign from malignant. Size, number of pol-
yps, and age of the patient are the clinical data that are 
used. But these factors are not sufficient in deciding which 
surgical procedures are appropriate, especially in polyps 
around 10 mm. Improved diagnostic methods are needed 
to differentiate between benign and malignant GB polyps, 
and to determine which polyps require operation [9-12]. 
If we can differentiate cholesterol polyps from non-cho-
lesterol polyps, it may be the first step in detecting wheth-
er the polyp has the likelihood of being a malignant one. 
Therefore, we evaluated clinical data which would be 
helpful in distinguishing cholesterol polyps from non- 
cholesterol polyps. 
This is a retrospective study on analyzing preoperative 
USG and CT findings compared with their postoperative 
gross and microscopic findings associated with the pa-
tients' clinical data. 
METHODS
Between January 2000 and December 2009, 359 patients 
underwent cholecystectomy under the diagnosis of GB 
polyp of around 10 mm. Only 187 patients (182 laparo-
scopic, 5 open) were diagnosed with GB polyp of any kind 
postoperatively and the 187 patients were enrolled in this 
study. The patients were divided into two groups (146 in 
cholesterol polyp group and 41 in non-cholesterol polyp 
group) based on the postoperative pathological findings, 
retrospectively.
Clinical features such as gender, age, bodyweight, body 
mass index (BMI), symptoms, laboratory findings, size, 
number of polyps, presence of GB stone, maximum diam-
eter measured by preoperative radiologic findings of the 
USG, CT, and the pathological diameter of the postopera-
tive findings were subjected to comparative analysis. 
For comparison, the GB polyps were measured on every 
CT view and the longest was accepted as the polyp length. 
The specimen was fixed in formalin within 20 minutes and 
was sent to the pathology department and entirely em-
bedded for pathological comparison. Results were re-
ported as the mean ± standard deviation. For statistical 
analysis, a chi-square, t-test and Mann-Whitney U test 
were used PASW ver. 18 (IBM, New York, NY, USA). A 
P-value < 0.05 was considered statistically significant.
RESULTS
Clinical findings of the GB polyps
Of the 187 patients, 79 patients were female and 108 
were male. The percentage of cholesterol polyps were 
higher in both sexes (78.48% in female, 77.77% in male) but 
there were no statistically significant differences in the 
gender ratio between the cholesterol polyp group (M:F = 
1.35:1) and the non-cholesterol polyp group (M:F = 1.41:1). 
The mean ages were 41.59 ± 11.36 for the cholesterol group 
and 46.37 ± 12.89 for the non-cholesterol group, which 
showed significantly different results between the two 
groups (P = 0.024) (Table 1).
Twelve patients had presenting symptoms of right up-
per quadrant pain and discomfort (7 in cholesterol polyps, 
5 in non-cholesterol polyps). One hundred and fifty-seven 
cases were associated with chronic cholecystitis (130 in Hye-Lin Song, et al.
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Table 2. Operation data
Operation data 
Non-cholesterol 
polyp 
Cholesterol 
polyp 
P-value 
Anesthesia time (min)  65   60 0.18
Operation time (min)  30   30 0.16
Hospital day    5     5 0.21
Postoperative day    3     3 0.09
Laparoscopic 40 142
Open    1     4
Conversion    0     0
Table 3. Pathological findings
Cholesterol 
polyp (146)
Non-cholesterol 
polyp (41)
Non-polyp (172)
Inflammatory polyp (2)
Fibrous polyp (2)
Hyperplastic polyp (9)
Adenomatous polyp (27)
Malignant polyp (1)
a)
Stone or sludge
Inflammation
Adenomyomatosis
Porcelain gallbladder
a)The malignant polyp was an adenocarcinoma, well differen-
tiated on the fundus with background tubular adenoma which 
was unable to be differentiated on preoperative image studies.
Table 4. Pathologic data
Pathologic data  Non-cholesterol polyp Cholesterol polyp
Solitary  37 (90.24) 59 (40.41)
Multiple  4 (9.76) 87 (59.59)
Gallbladder stone   9 (22.00) 43 (29.00)
Values are presented as number (%).
Table 5. Size data of non-cholesterol polyps
Non-cholesterol 
polyp 
CT USG Pathology 
Size (mm)  9 ± 5.56  10 ± 4.28  10 ± 4.37 
Correlation coefficient
 (P-value) 
CT  1.00 (0) 0.708 (0.000)  0.625 (0.000) 
USG  0.708 (0.000)    1.00 (0) 0.628 (0.000) 
Pathology  0.625 (0.000)  0.628 (0.000)   1.00 (0)
CT, computed tomography; USG, ultrasonography.
cholesterol polyps, 27 in non-cholesterol polyps). Forty- 
three cases of cholesterol polyps (29%) and 9 cases for 
non-cholesterol polyps were associated with a GB stone. 
The mean BMI was 24.70 ± 3.18 in the cholesterol polyp 
group and 22.70 ± 2.91 in the non-cholesterol polyp group, 
which was significantly different between the two groups 
(P = 0.01) [13,14]. The cholesterol level was 185.02 ± 34.3 in 
the cholesterol polyp group and 181.48 ± 38.45 in the 
non-cholesterol polyp group but there were no significant 
differences between the two groups (P=0.6) (Table 1).
The data related with operation in both cholesterol pol-
yp and non-cholesterol polyp were evaluated and showed 
no significant difference between the two groups (opera-
tion time, hospital day, postoperative day, conversion 
rate). Four cases of the cholesterol polyp group and 1 case 
of the non-cholesterol polyp group were considered to be 
open on the preoperative state because of the history of 
previous abdominal surgery and the consideration of duc-
tal damage due to adhesion (Table 2).
Pathological findings of the GB polyps
Of the 187 cases, 146 (78.1%) were cholesterol polyps 
[11] and 41 (21.9%) were non-cholesterol polyps. Of the 41 
non-cholesterol polyps 2 were inflammatory polyps and 2 
were fibrous polyps, 9 hyperplastic polyps, 27 ad-
enomatous polyps (65.85%) and 1 malignant polyp (Table 
3) [10].
As a result, 59.59% of the cholesterol polyps was 
multiple. In contrast, 90.24% was solitary polyps in the 
non-cholesterol polyp group. But the percentage of associ-
ating GB stones were almost the same between the two 
groups (29% in cholesterol polyp group, 22% in non-cho-
lesterol polyp group) (Table 4).
The discrepancy in maximum diameter between 
USG and CT finding
The preoperative mean maximum diameters measured 
by the USG in the cholesterol group and the non-cholester-
ol group were 10 ± 3.2 mm and 10 ± 4.28 mm, retro-
spectively; whereas by CT they were 9 ± 4.73 mm and 9 ± 
5.56 mm, retrospectively. The mean diameters from CT 
scanning tended to be smaller than from the USG in both 
groups. 
The difference in maximum diameters between the 
USG and the CT findings were 2.64 mm in cholesterol pol-Clinical and radiologic preoperative predicting factors for GB cholesterol polyp
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Cholesterol 
poyp 
CT USG Pathology
Size (mm)  9 ± 4.73 10 ± 3.2 5 ± 3.00
Correlation coefficient
 (P-value) 
   CT   1.00 (0) 0.422 (0.001) 0.194 (0.124)
   USG 0.422 (0.001)  1.00 (0) 0.331 (0.001)
   Pathology 0.194 (0.124) 0.331 (0.001)   1.00 (0)
CT, computed tomography; USG, ultrasonography.
Table 6. Size data of cholesterol polyps Table 7. Radiologic data of cholesterol polyps
Radiologic data 
Non-cholesterol 
polyp
Cholesterol 
polyp
P-value
USG found only (%) 8 28.6 0.032
CT-USG size diff (mm)  0.94 2.64 0.04
USG, ultrasonography; CT, computed tomography; diff, diffe-
rence.
yps and 0.94 mm in the non-cholesterol polyp group and 
the difference was statistically significant (P = 0.04) (Tables 
5, 6).
The correlation between radiologically measured 
and pathologically measured polyp diameters
The mean maximum diameters measured pathologi-
cally were 5 ± 3.00 mm in cholesterol polyps and 10 ± 4.37 
mm in non-cholesterol polyps. The correlation coefficient 
between USG, CT, and pathologic size was compared in 
both groups shown to be 0.71 cm (P = 0.000) in the non-cho-
lesterol polyp group and 0.082 cm (P = 0.167) in the choles-
terol polyp group. 
Of the non-cholesterol polyp group the correlation co-
efficient between the USG and the CT was 0.708 (P = 0.000) 
while it was 0.422 (P = 0.001) in the cholesterol polyp 
group. The correlation coefficient between the USG and 
pathology was 0.625 (P = 0.000) in the non-cholesterol pol-
yp group and 0.331 (P = 0.001) in the cholesterol polyp 
group (Tables 5, 6).
The radiologic detection of cholesterol and non- 
cholesterol polyps
Unfortunately, 28.6% of the cholesterol polyps was not 
found in the preoperative CT, which was able to be de-
tected on the USG. But the percentage of the undetectable 
rate was significantly lower (8%, P = 0.032) than in the 
non-cholesterol polyp group. This means, if the pre-
operative radiologic finding shows polyps only in the 
USG, it can be more likely a cholesterol polyp than a 
non-cholesterol polyp (Table 7).
DISCUSSION
Though a laparoscopic cholecystectomy can be consid-
ered a less complicated operation, an operation that is un-
necessary is truly a burden to the patient and a waste of 
cost. To prevent these operations, the diagnosis of GB pol-
yps has to be made correctly. This study was intended to 
characterize the clinical features of the cholesterol polyp 
and to determine the accurate radiological predictive 
factors. 
Age is a known risk factor associated with malignancy 
[13-15]. This study also showed a higher mean age in the 
non-cholesterol polyp group. Many studies show the rela-
tionship between metabolic syndrome and the develop-
ment of cholesterol polyps [2,16,17]. Our study showed a 
significant data of higher BMI in cholesterol polyps com-
pared to non-cholesterol polyps [11]. And the cholesterol 
level was higher in the cholesterol polyp group without 
significant difference. 
It is known that a single polyp is more likely to be a ma-
lignant polyp [13,18]. If a single polyp is identified it needs 
more aggressive work up or more aggressive inter-
ventions than multiple polyps. Among our study pop-
ulations, over 90% of the non-cholesterol polyps was soli-
tary and about 60% of cholesterol polyps was multiple 
polyps. In other words our study also shows a need for ag-
gressive work up in solitary polyps as the ratio is higher in 
non-cholesterol polyps. Many studies have reported that 
polyps over 10 mm have a high risk of being a malignancy, 
and this is surgical criteria for treating GB polyps 
[11,19-21]. The pathologic size of the polyps in our study 
also had a similar tendency. But there were many choles-
terol polyps larger than 10 mm in the group. Therefore, it 
is hard to state size as a definite factor to distinguish be-
nign from malignant polyps [22-25]. Hye-Lin Song, et al.
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We observed discrepancies between preoperative ra-
diological measurements and postoperative pathologic 
measurements in the cholesterol polyp group. And the 
cholesterol polyp group also showed low correlation co-
efficients between the three measured sizes. The damage 
of cholesterol polyps during operation or handling after 
obtaining the GB may explain the results. As a result, the 
preoperative radiologic studies are limited in obtaining 
the correct measurements for cholesterol polyps. On the 
contrary, non-cholesterol polyps have a high correlation 
coefficient between the preoperative diameters measured 
by USG and CT. And the correlation coefficiency com-
pared with the USG and CT of postoperative pathologic 
diameters are also significantly high. 
The predictive preoperative radiologic signs for a 
non-cholesterol polyp include a single polyp, observable 
on both the USG and CT, and a discrepancy of the max-
imum diameter less than 1 mm between the USG and CT. 
In conclusion, young patients with high BMI and high 
cholesterol levels who have multiple GB polyps near 10 
mm in size measured by USG can be recommended a CT 
scan [26-28]. And if the diameter has a discrepancy or only 
seen in the USG, the GB polyp can be considered as a cho-
lesterol polyp and require planning for another follow-up 
after 6 months [29,30] thereby delaying the operation. We 
suggest that it would be more efficient to make flexible 
treatment plans for the mentioned cases rather than the 
fixed guideline. 
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